NCT00617799 2023-10-10
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
University of Nebraska
Completed
University of Nebraska
University of Nebraska
Barbara Ann Karmanos Cancer Institute
Fuda Cancer Hospital, Guangzhou
Ohio State University Comprehensive Cancer Center
SWOG Cancer Research Network
Cytheris SA